KRISTIN ESENWEIN: Open Payments
NPI 1861052953 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 27 payments from 6 companies in 2025. Trend: 2023 $1,205 · 2024 $524 · 2025 $582
Food & beverage: $483Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $238 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Genentech USA, Inc. | 1 | $25 |
| Organon LLC | 1 | $8 |
Products named: DUPIXENT, NEFFY, FASENRA, Rhapsido, Xolair, TEZSPIRE.
Industry payments across AL — which companies pay providers there.
